Long-term treatment of autosomal dominant polycystic kidney disease (ADPKD) with venglustat

Trial Identifier: LTS15823
Sponsor: sanofi
Start Date: February 2021
Primary Completion Date: July 2021
Study Completion Date: July 2021
Condition: Kidney Diseases

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
Australia, New South Wales Westmead, New South Wales, Australia, 2145
Belgium Leuven, Belgium, 3000
Germany Berlin, Germany, 10117
Japan, Hokkaido Sapporo-shi, Hokkaido, Japan, 060-8648
Japan, Osaka Osaka-shi, Osaka, Japan, 545-8586
Japan, Tokyo Bunkyo-ku, Tokyo, Japan, 113-8431
Japan, Tokyo Shinjuku-ku, Tokyo, Japan, 162-8666
Netherlands Nijmegen, Netherlands, 6525GA
South Korea, Seoul-teukbyeolsi Seoul, Seoul-teukbyeolsi, South Korea, 07061
Spain, Barcelona [Barcelona] Barcelona, Barcelona [Barcelona], Spain, 08003
United States, West Virginia Morgantown, West Virginia, United States, 26506-9180